ArticleResearch (Washington, D.C.)2025
Self-Organized Vascularized Hepatic Organoids in Microcapsules for Liver Regeneration.
Article in Research (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A Machine Vision-Guided Microphysiological Platform With Automated Microfluidics Enables Longitudinal Biomarker Monitoring and Emulation of Translationally Relevant Exposure Scenarios.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Organoids in Pediatric Congenital Hepatobiliary Diseases: Current Status and Progress in Clinical Translational Research.Biomedicines · 2026Review
- Benchmarking of Decellularization Protocols for Small Intestinal Submucosa: Defining the Gold Standard for Functional Tissue Engineering.Materials (Basel, Switzerland) · 2026Article
- Review
- Microengineering the Liver: Strategies for Constructing Functional Liver-on-a-Chip Devices.Exploration (Beijing, China) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic organoids represent a promising strategy for liver regeneration; however, challenges remain in flexibly tailoring them to achieve complex architectures and vascularized structures for enhanced functionality. Here, we propose a novel system of self-organized vascularized hepatic organoids (SOVHOs) encapsulated in hydrogel microcapsules with biomimetic features for liver regeneration. The hydrogel shell microcapsules encapsulating human umbilical vein endothelial cells and hepatic organoids derived from human induced pluripotent stem cells were generated using microfluidic encapsulation technology. The hydrogel shell provides a 3-dimensional culture environment that supports the formation of uniform hepatocyte spheroids with vascular networks inside the microcapsules. The SOVHOs exhibit liver-specific functions, including drug metabolism, urea synthesis, and serum protein production. In rats with acute liver failure, we demonstrated that the SOVHOs markedly enhanced survival rate and normalize the inflammatory response after transplantation, indicating their remarkable repopulation capacity in facilitating injured liver recovery. Furthermore, SOVHOs remained viable in the host liver for at least 7 days post-implantation, exhibiting low immunogenicity and no detectable adverse effects in rats during this period. These results suggest that our SOVHOs are potentially valuable for clinical application in liver disease treatment.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.